Considering the ICGC/TCGA analysis that several cancer pathways showed a positive correlation with the ratio of AIMP2-DX2/AIMP2 in AML, we extended our analysis using ML-1 AML cells. Here, AIMP2 is linked to acute myeloid leukemia.